Corestate Capital (CCAP) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
5 Sep, 2025Executive summary
Strategic realignment focused on value-maximizing sales of non-core assets, supporting Hannover Leasing, and divesting STAM France, with completion expected mid-September 2025.
Operational resilience demonstrated in a challenging market, with continued commitment to deleveraging and meeting debt obligations.
Financial highlights
Aggregated revenue and gains for H1 2025 were €14.0m, down from €15.5m in H1 2024.
EBITDA for H1 2025 was €-8.3m, compared to €11.8m in H1 2024.
Net profit for H1 2025 was €-21.2m, versus €28.0m in H1 2024; adjusted net profit was €-19.4m.
Earnings per share for H1 2025 was €-0.1, down from €0.2 in H1 2024.
Cash and cash equivalents as of June 30, 2025, were €18.7m; net debt increased to €209.1m.
Outlook and guidance
Full repayment of the Super Senior Note, including accrued PIK interest, targeted by end of 2025.
Repayments on Reinstated Senior Notes expected to begin by end of 2025 or early 2026.
Additional asset disposals are in preparation to support deleveraging.
Latest events from Corestate Capital
- Significant losses and deleveraging mark a challenging transition to a holding structure.CCAP
Q3 20255 Jan 2026 - Restructuring nearly complete; focus shifts to asset sales and deleveraging amid market headwinds.CCAP
Q4 20248 Aug 2025 - Revenue up, profits down; asset sales and debt repayment drive 2025 strategy.CCAP
Q1 202517 Jun 2025 - Net loss, lower equity, and delayed asset sales mark Corestate's ongoing restructuring.CCAP
Q3 202413 Jun 2025 - EBITDA loss narrowed and asset sales accelerated, but AUM and equity ratio declined.CCAP
Q2 202413 Jun 2025 - Losses narrowed and asset sales progressed, but liquidity remains a key challenge.CCAP
Q1 202413 Jun 2025